Letter To Shareholders from Chairman Ilya Shpurov
09 nov. 2020 09h15 HE
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus , Nov. 09, 2020 (GLOBE NEWSWIRE) -- November 9, 2020 (GLOBE NEWSWIRE) Rafarma Pharmaceuticals, Inc. OTC:(RAFA) shares the following letter to shareholders from Chairman Ilya Shpurov:...
Auditing Firm L J Soldinger Associates Retained for Rafarma Biocogency Merger
04 nov. 2020 09h01 HE
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that the elite Chicago auditing firm LJ Soldinger Associates...
Rafarma Closes Biocogency Merger
19 oct. 2020 09h15 HE
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has closed the merger with BIOCOGENCY LABORATORIES. The new consolidated...
Rafarma Approves Issuance of Majority of Voting Shares to Board Chairman Ilya Shpurov
06 oct. 2020 10h13 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce approval of Ilya Shpurov receiving the majority of Preferred B shares,...
Rafarma Adds Prestigious New Board Chairman Ilia Shpurov
18 sept. 2020 09h32 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce the appointment of Ilia Shpurov as Chairman of the Board. Mr. Shpurov has a...
Rafarma Conducts Strategy Conference in Thailand for University and Hospital Joint Venture
02 sept. 2020 11h01 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reports that Mr. Anucha Pehtpeng, Rafarma’s Director of Thai Operations, represented the company...
Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects
25 août 2020 11h13 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is pleased to announce that it has established a new corporate entity in Thailand. The entity is...
Rafarma - Biocogency Acquisition Progresses to Preparation of GAAP Financials and Form 10 Drafting for Full SEC Reporting
14 août 2020 09h15 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to update its shareholders on the progress of its acquisition by the R. & D. BIOCOGENCY...
Letter to Shareholders Regarding Rafarma Acquisition by R. & D. Biocogency Laboratories Inc.
05 août 2020 09h15 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) presents the following letter to Rafarma shareholders from CEO Vladimir Dolgolenko: To Our...
Rafarma to be Acquired by R. & D. Biocogency Laboratories Inc.
04 août 2020 09h15 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency...